Click Therapeutics
We're Hiring!
Click Therapeutics Leadership & Management
What People Are Saying About Click Therapeutics
-
Strategic Vision & Planning: Leadership articulates a coherent “software as medicine” thesis, reinforced by the April 2025 rebrand and a two‑pillar approach spanning prescription digital therapeutics and software‑enhanced drugs. Public messaging and executive remarks indicate continuity rather than frequent pivots.
-
Strong Execution: Evidence includes FDA authorizations for Rejoyn and CT‑132, alongside the April 2026 Boehringer Ingelheim agreement transferring CT‑155 commercialization responsibilities to Click with dedicated funding.
-
Collaborative & Aligned Leadership: The leadership roster spans strategy, commercial, technology, medical, legal, product, engineering, and business development. The organization is described as integrating capabilities across technology, medical, regulatory, commercial, and partnerships to support the stated strategy.
Click Therapeutics's Benefits
Hosts in-person all-hands meetings
Implements team-based strategic planning
Open office floor plan to encourage communication and collaboration
Uses an OKR operational model to clearly define goals and priorities
Utilizes an open door policy that encourages accessibility
